Krebs Von den Lungen-6 as a predictive indicator for the risk of secondary pulmonary fibrosis and its reversibility in COVID-19 patients

被引:0
|
作者
Xue, Mingshan [1 ]
Zhang, Teng [2 ]
Chen, Hao [3 ]
Zeng, Yifeng [3 ]
Lin, Runpei [3 ]
Li, Ning [3 ]
Huang, Zhifeng [3 ]
Zhou, Luqian [3 ]
Zhang, Xiaohua Douglas [2 ]
Sun, Baoqing [3 ]
机构
[1] Guangzhou Lab, Guangzhou, Peoples R China
[2] Univ Macau, Fac Hlth Sci, Guangzhou, Peoples R China
[3] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou, Peoples R China
关键词
D O I
10.1183/13993003.congress-2023.PA3836
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [21] KREBS VON DEN LUNGEN-6 (KL-6) IN CEREBROSPINAL FLUID FROM NEUROSARCOIDOSIS PATIENTS
    Bocci, Silvia
    d'Alessandro, Miriana
    Bergantini, Laura
    Cerase, Alfonso
    Ulivelli, Monica
    Rottoli, Paola
    Cavallaro, Dalila
    Gangi, Sara
    Bargagli, Elena
    Giannini, Fabio
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2023, 40 (02)
  • [22] Comparative study between corticosteroids and colchicine effect on interleukin-6 and Krebs-von-den Lungen-6 in treatment of post covid pulmonary fibrosis
    Bedir, Mohamed A. E. G.
    Elemery, Fawzy A. E.
    Elghafar, Mohamed T. A.
    Torky, Mohamed
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2024, 73 (03): : 225 - 232
  • [23] Krebs von den Lungen-6 (KL-6) as a diagnostic marker for pulmonary fibrosis: A systematic review and meta-analysis
    Wang, Chuanzhu
    Wang, Qingbao
    Liu, Tong
    Zhu, Jun
    Zhang, Boke
    CLINICAL BIOCHEMISTRY, 2023, 114 : 30 - 38
  • [24] PROGNOSTIC VALUE OF SERUM KREBS VON DEN LUNGEN-6 GLYCOPROTEIN CIRCULATING LEVELS IN COVID-19 PNEUMONIA: A PROSPECTIVE COHORT STUDY
    Lobo Prat, D.
    Castellvi, I.
    Castillo, D.
    Orozco, S.
    Mariscal, A.
    Martinez-Martinez, L.
    Millan Arciniegas, A. M.
    Moya, P.
    Laiz, A.
    Diaz-Torne, C.
    Magallares, B.
    Fernandez-Sanchez, S. P.
    Jeria Navarro, S.
    Sainz Comas, L.
    Codes, H.
    Casademont, J.
    Domingo, P.
    Corominas, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1365 - 1365
  • [25] Krebs von den Lungen 6 (KL-6) levels in COVID-19 ICU patients are associated with mortality
    Scarpati G.
    Baldassarre D.
    Boffardi M.
    Calabrese V.
    De Robertis E.
    Lacava G.
    Oliva F.
    Pagliano P.
    Pascale G.
    Tripepi G.L.
    Piazza O.
    Journal of Anesthesia, Analgesia and Critical Care, 2 (1):
  • [26] Krebs von den Lungen-6 (KL-6) Levels in Post-COVID Follow-Up: Differences According to the Severity of COVID-19
    Carpio, Carlos
    Qasem, Ana
    Buno, Antonio
    Borobia, Alberto M.
    Arnalich, Francisco
    Rey, Vega
    Lazaro, Teresa
    Mariscal, Pablo
    Laorden, Daniel
    Salgueiro, Giorgina
    Moreno, Alberto
    Peiro, Concepcion
    Lorenzo, Oscar
    Alvarez-Sala, Rodolfo
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (19)
  • [27] Serum Krebs von den Lungen-6 for Predicting the Severity of COVID-19: A Systematic Review, Meta-Analysis, and Trial Sequence Analysis
    Shrestha, Abhigan Babu
    Pokharel, Pashupati
    Singh, Harendra
    Shrestha, Sajina
    Fioni
    CLINICAL MEDICINE INSIGHTS-CIRCULATORY RESPIRATORY AND PULMONARY MEDICINE, 2023, 17
  • [28] Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease
    Benyamine, Audrey
    Heim, Xavier
    Resseguier, Noemie
    Bertin, Daniel
    Gomez, Carine
    Ebbo, Mikael
    Harle, Jean-Robert
    Kaplanski, Gilles
    Rossi, Pascal
    Bardin, Nathalie
    Granel, Brigitte
    RHEUMATOLOGY INTERNATIONAL, 2018, 38 (05) : 813 - 819
  • [29] Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease
    Audrey Benyamine
    Xavier Heim
    Noémie Resseguier
    Daniel Bertin
    Carine Gomez
    Mikaël Ebbo
    Jean-Robert Harlé
    Gilles Kaplanski
    Pascal Rossi
    Nathalie Bardin
    Brigitte Granel
    Rheumatology International, 2018, 38 : 813 - 819
  • [30] Krebs von den Lungen-6 glycoprotein circulating levels are not useful as prognostic marker in COVID-19 pneumonia: A large prospective cohort study
    Castellvi, Ivan
    Castillo, Diego
    Corominas, Hector
    Mariscal, Anais
    Orozco, Sandra
    Benito, Natividad
    Pomar, Virginia
    Baucells, Andres
    Mur, Isabel
    de la Rosa-carrillo, David
    Lobo, David
    Millan, Ana Milena
    Hernandez de Sosa, Nerea
    Filella, David
    Matas, Laia
    Martinez-Martinez, Laura
    Juarez, Candido
    Casademont, Jordi
    Domingo, Pere
    FRONTIERS IN MEDICINE, 2022, 9